Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity

The effects of the nondepolarizing muscle relaxants (NDMR), pancuronium, vecuronium, and d-tubocurarine and a depolarizing muscle relaxant, succinylcholine, were studied on choline acetyltransferase (ChAT) activity. A radiochemical assay was used in the determination of ChAT activity using purified...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of anesthesia 1990-09, Vol.37 (6), p.690-694
Hauptverfasser: KAMBAM, J. R, JANSON, V. E, DAY, P, SASTRY, B. V. R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 694
container_issue 6
container_start_page 690
container_title Canadian journal of anesthesia
container_volume 37
creator KAMBAM, J. R
JANSON, V. E
DAY, P
SASTRY, B. V. R
description The effects of the nondepolarizing muscle relaxants (NDMR), pancuronium, vecuronium, and d-tubocurarine and a depolarizing muscle relaxant, succinylcholine, were studied on choline acetyltransferase (ChAT) activity. A radiochemical assay was used in the determination of ChAT activity using purified placental enzyme. Pancuronium at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 3, 10, 15, 40 and 85 per cent, respectively; vecuronium at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 5, 10, 26 and 57 per cent, respectively; d-tubocurarine at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 0, 4, 12.5 and 29 per cent, respectively; whereas succinylcholine at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, and 10(-4) M activated ChAT activity by 8, 10, 1, and 2 per cent, respectively. Even though our present data demonstrated a significant dose-dependent inhibitory effect on ChAT activity by pancuronium, vecuronium and d-tubocurarine, it is unlikely that this inhibitory effect will contribute to the mechanism of action of NDMR. Our data, however, may suggest an additional mechanism for the phenomena of tetanic and train-of-four fades that are seen following the administration of nondepolarizing muscle relaxants.
doi_str_mv 10.1007/BF03006494
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80017612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80017612</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-7051680868ec4804e6f3c2c097ab7096264aa265d953680e26759c5738a909a3</originalsourceid><addsrcrecordid>eNpNkEtLA0EQhAdRYoxevAu56EFc7dmZncdRg1EhoIccvC2dySyO7EPnEci_d2Mi8dRN1UfRXYScU7ilAPLuYQoMQHDND8iQci0ypWVxSIagWJ4JCu_H5CSETwBQolADMqBaCs7VkKQ3bE3yXetSczNe2f2O7XK8zGJadL2G3rV27NoPt3Dx1wrJGNeua_PR1RsvRNekGqMN4z8JjY3rOnpsQ2U9ho0S3crF9Sk5qrAO9mw3R2Q-fZxPnrPZ69PL5H6WGQYyZhIKKlR_s7KGK-BWVMzkBrTEhQQtcsERc1EsdcF6zuZCFtoUkinUoJGNyNU29st338mGWDYuGFvX2NouhVIBUClo3oPXW9D4LgRvq_LLuwb9uqRQbiou9xX38MUuNS0au9yj2057_3LnYzBYV_3_xoV_WC6Z5Dn7ASI2hJY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80017612</pqid></control><display><type>article</type><title>Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>KAMBAM, J. R ; JANSON, V. E ; DAY, P ; SASTRY, B. V. R</creator><creatorcontrib>KAMBAM, J. R ; JANSON, V. E ; DAY, P ; SASTRY, B. V. R</creatorcontrib><description>The effects of the nondepolarizing muscle relaxants (NDMR), pancuronium, vecuronium, and d-tubocurarine and a depolarizing muscle relaxant, succinylcholine, were studied on choline acetyltransferase (ChAT) activity. A radiochemical assay was used in the determination of ChAT activity using purified placental enzyme. Pancuronium at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 3, 10, 15, 40 and 85 per cent, respectively; vecuronium at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 5, 10, 26 and 57 per cent, respectively; d-tubocurarine at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 0, 4, 12.5 and 29 per cent, respectively; whereas succinylcholine at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, and 10(-4) M activated ChAT activity by 8, 10, 1, and 2 per cent, respectively. Even though our present data demonstrated a significant dose-dependent inhibitory effect on ChAT activity by pancuronium, vecuronium and d-tubocurarine, it is unlikely that this inhibitory effect will contribute to the mechanism of action of NDMR. Our data, however, may suggest an additional mechanism for the phenomena of tetanic and train-of-four fades that are seen following the administration of nondepolarizing muscle relaxants.</description><identifier>ISSN: 0832-610X</identifier><identifier>EISSN: 1496-8975</identifier><identifier>DOI: 10.1007/BF03006494</identifier><identifier>PMID: 1976448</identifier><identifier>CODEN: CJOAEP</identifier><language>eng</language><publisher>Toronto, ON: Canadian Anesthesiologists' Society</publisher><subject>Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Carbon Radioisotopes ; Choline O-Acetyltransferase - antagonists &amp; inhibitors ; Choline O-Acetyltransferase - metabolism ; Dose-Response Relationship, Drug ; Ion Exchange Resins ; Medical sciences ; Neuropharmacology ; Pancuronium - administration &amp; dosage ; Pancuronium - pharmacology ; Pharmacology. Drug treatments ; Regression Analysis ; Succinylcholine - administration &amp; dosage ; Succinylcholine - pharmacology ; Tubocurarine - administration &amp; dosage ; Tubocurarine - pharmacology ; Vecuronium Bromide - administration &amp; dosage ; Vecuronium Bromide - pharmacology</subject><ispartof>Canadian journal of anesthesia, 1990-09, Vol.37 (6), p.690-694</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-7051680868ec4804e6f3c2c097ab7096264aa265d953680e26759c5738a909a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19273742$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1976448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAMBAM, J. R</creatorcontrib><creatorcontrib>JANSON, V. E</creatorcontrib><creatorcontrib>DAY, P</creatorcontrib><creatorcontrib>SASTRY, B. V. R</creatorcontrib><title>Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity</title><title>Canadian journal of anesthesia</title><addtitle>Can J Anaesth</addtitle><description>The effects of the nondepolarizing muscle relaxants (NDMR), pancuronium, vecuronium, and d-tubocurarine and a depolarizing muscle relaxant, succinylcholine, were studied on choline acetyltransferase (ChAT) activity. A radiochemical assay was used in the determination of ChAT activity using purified placental enzyme. Pancuronium at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 3, 10, 15, 40 and 85 per cent, respectively; vecuronium at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 5, 10, 26 and 57 per cent, respectively; d-tubocurarine at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 0, 4, 12.5 and 29 per cent, respectively; whereas succinylcholine at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, and 10(-4) M activated ChAT activity by 8, 10, 1, and 2 per cent, respectively. Even though our present data demonstrated a significant dose-dependent inhibitory effect on ChAT activity by pancuronium, vecuronium and d-tubocurarine, it is unlikely that this inhibitory effect will contribute to the mechanism of action of NDMR. Our data, however, may suggest an additional mechanism for the phenomena of tetanic and train-of-four fades that are seen following the administration of nondepolarizing muscle relaxants.</description><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Carbon Radioisotopes</subject><subject>Choline O-Acetyltransferase - antagonists &amp; inhibitors</subject><subject>Choline O-Acetyltransferase - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Ion Exchange Resins</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pancuronium - administration &amp; dosage</subject><subject>Pancuronium - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Regression Analysis</subject><subject>Succinylcholine - administration &amp; dosage</subject><subject>Succinylcholine - pharmacology</subject><subject>Tubocurarine - administration &amp; dosage</subject><subject>Tubocurarine - pharmacology</subject><subject>Vecuronium Bromide - administration &amp; dosage</subject><subject>Vecuronium Bromide - pharmacology</subject><issn>0832-610X</issn><issn>1496-8975</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtLA0EQhAdRYoxevAu56EFc7dmZncdRg1EhoIccvC2dySyO7EPnEci_d2Mi8dRN1UfRXYScU7ilAPLuYQoMQHDND8iQci0ypWVxSIagWJ4JCu_H5CSETwBQolADMqBaCs7VkKQ3bE3yXetSczNe2f2O7XK8zGJadL2G3rV27NoPt3Dx1wrJGNeua_PR1RsvRNekGqMN4z8JjY3rOnpsQ2U9ho0S3crF9Sk5qrAO9mw3R2Q-fZxPnrPZ69PL5H6WGQYyZhIKKlR_s7KGK-BWVMzkBrTEhQQtcsERc1EsdcF6zuZCFtoUkinUoJGNyNU29st338mGWDYuGFvX2NouhVIBUClo3oPXW9D4LgRvq_LLuwb9uqRQbiou9xX38MUuNS0au9yj2057_3LnYzBYV_3_xoV_WC6Z5Dn7ASI2hJY</recordid><startdate>19900901</startdate><enddate>19900901</enddate><creator>KAMBAM, J. R</creator><creator>JANSON, V. E</creator><creator>DAY, P</creator><creator>SASTRY, B. V. R</creator><general>Canadian Anesthesiologists' Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900901</creationdate><title>Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity</title><author>KAMBAM, J. R ; JANSON, V. E ; DAY, P ; SASTRY, B. V. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-7051680868ec4804e6f3c2c097ab7096264aa265d953680e26759c5738a909a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Carbon Radioisotopes</topic><topic>Choline O-Acetyltransferase - antagonists &amp; inhibitors</topic><topic>Choline O-Acetyltransferase - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Ion Exchange Resins</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pancuronium - administration &amp; dosage</topic><topic>Pancuronium - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Regression Analysis</topic><topic>Succinylcholine - administration &amp; dosage</topic><topic>Succinylcholine - pharmacology</topic><topic>Tubocurarine - administration &amp; dosage</topic><topic>Tubocurarine - pharmacology</topic><topic>Vecuronium Bromide - administration &amp; dosage</topic><topic>Vecuronium Bromide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAMBAM, J. R</creatorcontrib><creatorcontrib>JANSON, V. E</creatorcontrib><creatorcontrib>DAY, P</creatorcontrib><creatorcontrib>SASTRY, B. V. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAMBAM, J. R</au><au>JANSON, V. E</au><au>DAY, P</au><au>SASTRY, B. V. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity</atitle><jtitle>Canadian journal of anesthesia</jtitle><addtitle>Can J Anaesth</addtitle><date>1990-09-01</date><risdate>1990</risdate><volume>37</volume><issue>6</issue><spage>690</spage><epage>694</epage><pages>690-694</pages><issn>0832-610X</issn><eissn>1496-8975</eissn><coden>CJOAEP</coden><abstract>The effects of the nondepolarizing muscle relaxants (NDMR), pancuronium, vecuronium, and d-tubocurarine and a depolarizing muscle relaxant, succinylcholine, were studied on choline acetyltransferase (ChAT) activity. A radiochemical assay was used in the determination of ChAT activity using purified placental enzyme. Pancuronium at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 3, 10, 15, 40 and 85 per cent, respectively; vecuronium at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 5, 10, 26 and 57 per cent, respectively; d-tubocurarine at concentrations of 10(-6) M, 10(-5) M, 10(-4) M, and 10(-3) M inhibited ChAT activity by 0, 4, 12.5 and 29 per cent, respectively; whereas succinylcholine at concentrations of 10(-7) M, 10(-6) M, 10(-5) M, and 10(-4) M activated ChAT activity by 8, 10, 1, and 2 per cent, respectively. Even though our present data demonstrated a significant dose-dependent inhibitory effect on ChAT activity by pancuronium, vecuronium and d-tubocurarine, it is unlikely that this inhibitory effect will contribute to the mechanism of action of NDMR. Our data, however, may suggest an additional mechanism for the phenomena of tetanic and train-of-four fades that are seen following the administration of nondepolarizing muscle relaxants.</abstract><cop>Toronto, ON</cop><pub>Canadian Anesthesiologists' Society</pub><pmid>1976448</pmid><doi>10.1007/BF03006494</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0832-610X
ispartof Canadian journal of anesthesia, 1990-09, Vol.37 (6), p.690-694
issn 0832-610X
1496-8975
language eng
recordid cdi_proquest_miscellaneous_80017612
source MEDLINE; SpringerLink Journals
subjects Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Carbon Radioisotopes
Choline O-Acetyltransferase - antagonists & inhibitors
Choline O-Acetyltransferase - metabolism
Dose-Response Relationship, Drug
Ion Exchange Resins
Medical sciences
Neuropharmacology
Pancuronium - administration & dosage
Pancuronium - pharmacology
Pharmacology. Drug treatments
Regression Analysis
Succinylcholine - administration & dosage
Succinylcholine - pharmacology
Tubocurarine - administration & dosage
Tubocurarine - pharmacology
Vecuronium Bromide - administration & dosage
Vecuronium Bromide - pharmacology
title Pancuronium, vecuronium, and d-tubocurarine inhibit and succinylcholine stimulates choline acetyltransferase activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T12%3A11%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancuronium,%20vecuronium,%20and%20d-tubocurarine%20inhibit%20and%20succinylcholine%20stimulates%20choline%20acetyltransferase%20activity&rft.jtitle=Canadian%20journal%20of%20anesthesia&rft.au=KAMBAM,%20J.%20R&rft.date=1990-09-01&rft.volume=37&rft.issue=6&rft.spage=690&rft.epage=694&rft.pages=690-694&rft.issn=0832-610X&rft.eissn=1496-8975&rft.coden=CJOAEP&rft_id=info:doi/10.1007/BF03006494&rft_dat=%3Cproquest_cross%3E80017612%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80017612&rft_id=info:pmid/1976448&rfr_iscdi=true